Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FL-2000 Study in Newly Diagnosed Follicular Lymphoma
NCT00136552Phase 3Completed
- Sponsor
- Lymphoma Study Association
- Start
- May 2000
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by Lymphoma Study Association. Started May 2000; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00136552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136552.